Impact of Nonpharmaceutical Interventions for Severe Acute Respiratory Syndrome Coronavirus 2 on Norovirus Outbreaks: An Analysis of Outbreaks Reported by 9 US States

Alicia N.M. Kraay, Peichun Han, Anita K. Kambhampati, Mary E. Wikswo, Sara A. Mirza, Benjamin A. Lopman

Research output: Contribution to journalArticlepeer-review

Abstract

In April 2020, the incidence of norovirus outbreaks reported to the National Outbreak Reporting System dramatically declined. We used regression models to determine if this decline was best explained by underreporting, seasonal trends, or reduced exposure due to nonpharmaceutical interventions (NPIs) implemented for severe acute respiratory syndrome coronavirus 2 using data from 9 states from July 2012 to July 2020. The decline in norovirus outbreaks was significant for all 9 states, and underreporting and/or seasonality are unlikely to be the primary explanation for these findings. These patterns were similar across a variety of settings. NPIs appear to have reduced incidence of norovirus, a nonrespiratory pathogen.

Original languageEnglish (US)
Pages (from-to)9-13
Number of pages5
JournalJournal of Infectious Diseases
Volume224
Issue number1
DOIs
StatePublished - Jul 1 2021
Externally publishedYes

Keywords

  • SARS-CoV-2
  • nonpharmaceutical interventions
  • norovirus
  • social distancing

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Impact of Nonpharmaceutical Interventions for Severe Acute Respiratory Syndrome Coronavirus 2 on Norovirus Outbreaks: An Analysis of Outbreaks Reported by 9 US States'. Together they form a unique fingerprint.

Cite this